Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bontac Bio-engineering is a leading synthetic biology company specializing in the research, development, and production of high-value coenzymes and natural products. Utilizing its proprietary "Bonzyme" whole-enzyme catalysis platform, the company manufactures key ingredients such as Nicotinamide Mononucleotide (NMN), NAD+, NADH, and rare sugars like D-allulose. Bontac serves the pharmaceutical, nutraceutical, and food industries globally, providing sustainable and high-purity bio-based solutions. The company is recognized for its green manufacturing processes and was among the first to commercialize NMN using enzymatic technology. With a strong emphasis on R&D, Bontac maintains an extensive patent portfolio and operates large-scale GMP-certified manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bontac Bio-engineering.